Merck KGaA

MRK: XETR (DEU)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
Bk^LOCK|Sfs?gLOCK|Xs?f#y$

Merck KGaA: SpringWorks Acquisition Strengthens Healthcare Portfolio; Shares Undervalued

Merck KGaA announced the acquisition of US biotech firm SpringWorks Therapeutics at an approximate enterprise value of EUR 3 billion. The transaction will be funded through a combination of cash and newly funded debt.

Sponsor Center